Case Report: A patient with residual craniopharyngioma experienced a rapid tumor relapse during growth hormone therapy. Objective: We present this case and remind physicians that it is necessary to reevaluate the safety of growth hormone therapy in patients with residual craniopharyngioma.
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Clinical Neurology